Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Immune checkpoint blockade (ICB) has demonstrated significant promise for the treatment of advanced malignancies. Anti-CTLA4 and ant-PD1 therapy can activate the immune system and result in durable control in diseases such as melanoma and non-small cell lung cancer. 109 RNASeq samples (58 On-treatment and 51 Pre-treatment) from 65 patients
创建时间：
2019-05-15
